Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,049–2,056 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Immunovant Inc. IMVT-1401 (ASCEND GO-2) Graves Ophthalmopathy / Thyroid Eye Disease (TED) Phase 2b Clinical Pause Subcutaneous Opthalmic
Immunovant Inc. Batoclimab Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Phase 2b Ongoing Intravenous Neurology
Immunovant Inc. Batoclimab Thyroid Eye Disease (TED) Phase 3 Ongoing Intravenous Opthalmic
Immunovant Inc. IMVT-1402 Autoimmune diseases, Graves' Disease Phase 3 Ongoing Subcutaneous Immunology
Immunovant Inc. Batoclimab Graves' Disease Phase 3 Trial Planned Intravenous Endocrinology
Immunovant Inc. Batoclimab (IMVT-1401) Myasthenia Gravis (MG) Phase 3 Data Released Subcutaneous Neurology
Immunovant Inc. Batoclimab (IMVT-1401) Thyroid eye disease (TED) Phase 3 Ongoing Subcutaneous Opthalmic
Immuron Limited Campylobacter ETEC Therapeutic Campylobacteriosis Phase 2 Oral N/A